๐ฐ Practice Management News
Page 19 - Practice Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Management. Real-time updates on events, politics, business and more.
February 15, 2024
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address...
February 15, 2024
The ABA Techshow 2024 opened at the Hyatt Regency Chicago on Wednesday, drawing legal professionals from around the world.
February 15, 2024
The former chief financial officer of McElroy, Deutsch, Mulvaney & Carpenter has been charged with theft and failure to pay taxes in connection with his alleged embezzlement of more than $1.5 million from the law firm.
February 14, 2024
Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.
February 14, 2024
Law firms returned to profitability in 2023 as โworked ratesโ accelerated throughout the year, according to the Law Firm Financial Index report for the fourth quarter of 2023 by the Thomson Reuters Institute.
February 14, 2024
A lawyer in Charlotte, North Carolina, put the knowledge that he gained at a fall conference to use when he visited a homeowner and averted a financial scam.
February 14, 2024
The STOP-CAD study signaled a short course of an antithrombotic regimen might lower ischemic stroke risk in some patients without significantly increasing major bleeding.
February 14, 2024
Dye & Durham (TSE:DND – Get Free Report) had its target price dropped by equities research analysts at CIBC from C$21.50 to C$21.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. CIBC’s target price indicates a potential upside of 67.73% from the […]
February 14, 2024
Fenwick & West is laying off nearly 10% of its lawyers and staff members, according to a memo by law firm chair Richard Dickson.
February 14, 2024
Biosimilars have driven down the costs of originator biologics, but it isn't clear whether those savings are being passed on to patients or increasing access to the drugs.